In this episode, we discuss how smaller and growing life science companies can implement GMP (Good Manufacturing Practice) in a way that ensures quality and compliance without slowing down development. Plantvision’s Karin Tördahl, together with senior consultant Jia Hwa Cheng, explains the differences between startups and established pharmaceutical companies, focusing on maturity, resources, and structure. The discussion highlights how a risk-based approach, pragmatic validation, and controlled use of manual processes can achieve the right level of GMP. We also talk about data integrity, supplier partnerships, and the importance of building a GMP culture early on. An episode for those who want to see GMP as an enabler of sustainable growth.